Boniva®
Understanding Boniva®
Boniva® (ibandronate) is a bisphosphonate medication used to treat and prevent osteoporosis in postmenopausal women by slowing bone loss and strengthening bones. It is an effective option for women seeking a monthly or quarterly treatment regimen to maintain bone strength and reduce the risk of fractures.
How Boniva® Works:
- Inhibits bone resorption, helping to slow bone loss.
- Strengthens bones and reduces the risk of fractures.
- Convenient dosing options, available as a once-monthly pill or quarterly intravenous (IV) infusion.
FDA Approval:
- Boniva® (ibandronate): Approved in 2003.
Speak with your healthcare provider to determine if Boniva® is the right treatment option for you.

Referral Form: |
WHAT IT TREATS: |
MANUFACTURER: Roche Therapeutics Inc. |
CLASS: Bisphosphonates |
PRESCRIBED BY:
|
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Once every three months. |
Length of infusion: 15 - 30 seconds |
FOR MORE INFORMATION:
|